Beijing Suncadia Pharmaceuticals Co., Ltd

This study tested a new medicine called SHR-1918, given as multiple shots under the skin, for people whose high cholesterol is not well controlled. About 44 adults with high cholesterol took part. The main goal was to see how much their 'bad' cholesterol (LDL-C) dropped after 24 …

This study tested a new injectable drug called SHR-1918 in 335 people with high cholesterol that was not well controlled by their current statin therapy. Participants received either SHR-1918 or a placebo alongside their usual cholesterol medications. The main goal was to see how…

This Phase 3 trial tested the drug SHR-1918 in 55 people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. Participants received either the drug or a placebo, and researchers measured how much their LDL (bad) choles…

This phase 2 trial tested an investigational drug called SHR-1918 in 26 people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. The study measured how much the drug lowered LDL (bad) cholesterol after 12 weeks. All…

This study tested a new drug called SHR-2004 to prevent dangerous blood clots in people undergoing elective total knee replacement. Over 1,100 adults participated, receiving either SHR-2004 or a standard blood thinner. The goal was to see if SHR-2004 could reduce clots in the leg…

This early-stage trial tested the safety and tolerability of a new drug called SHR-6934 in 88 healthy adults. Participants received either the drug or a placebo as a single or multiple injections under the skin. The goal was not to treat any disease, but to gather important safet…

This early-stage study tested the safety and tolerability of a new drug called HRS-8829 in 83 healthy adults aged 18 to 55. The drug is being developed for acute ischemic stroke. Participants received either the drug or a placebo, and researchers monitored side effects and how th…